🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Visual Adaptation and Quality of Life After Different IOL Implantation Strategies

Recruitingn/aAges 18 Years - 100 YearsAllSichuan Academy of Medical Sciences
NCT07740590 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This longitudinal observational study aims to evaluate long-term visual adaptation trajectories, optical quality, and patient-reported outcomes in age-related cataract patients following bilateral implantation of multifocal or mix-and-match intraocular lenses (IOLs). Patients will be followed up longitudinally after surgery to systematically assess visual performance and quality of life.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age 18 years or older with age-related cataract requiring bilateral phacoemulsification and intraocular lens (IOL) implantation * Corneal astigmatism less than 0.75 D * Good general health and willing to complete all postoperative follow-up visits * Signed written informed consent Exclusion Criteria: * Previous ocular surgery or ocular trauma * Coexisting ocular diseases affecting visual potential, such as corneal opacity, glaucoma, macular degeneration, or diabetic retinopathy * Intraoperative or postoperative complications (e.g., posterior capsule rupture) * Systemic diseases that may interfere with visual outcomes or follow-up compliance
💊

What it tests

  • Bilateral Bifocal IOL Implantation
  • Bifocal and EDOF IOL Mix-and-Match Implantation
  • Bifocal and Monofocal IOL Mix-and-Match Implantation
📍

Where

1 site
Sichuan Provincial People's Hospital
Chengdu, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy